Diagnostics News and Research

RSS

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).

5 Feb 2010

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).

5 Feb 2010

Health Discovery receives final patent infringement payment from Vermillion

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc.

4 Feb 2010

Researchers develop simple urine test to predict and diagnose preeclampsia

Researchers at Yale School of Medicine have developed a simple urine test to rapidly predict and diagnose preeclampsia, a common, but serious hypertensive complication of pregnancy.

4 Feb 2010

Inverness Medical Innovations to acquire Kroll's Substance Abuse Testing division

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.

4 Feb 2010

BD Diagnostics launches Be a Flu Fighter initiative to increase awareness and prevent influenza

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza.

From BD (Becton, Dickinson and Company) 3 Feb 2010

Home Diagnostics signs definitive merger agreement with Nipro

Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).

3 Feb 2010

Report: California biomedical industry faces unprecedented challenges

The biomedical industry is one of the most recession-resilient sectors in California's hard-hit economy and a critical driver of innovation, job growth and revenue that will help lead the state to economic recovery, according to a report released today by the California Healthcare Institute (CHI) and PricewaterhouseCoopers LLP (PwC).

3 Feb 2010

Micronics issued second letters patent from USPTO for integrated heat exchange system

Micronics, Inc. today announced that it has been issued a second letters patent from the United States Patent and Trademark Office (USPTO) for an integrated heat exchange system on a disposable, plastic cartridge.

3 Feb 2010

10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 10 new kits for the fast and simple isolation of nucleic acids from blood, plasma and serum, including circulating nucleic acids.

3 Feb 2010

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled “Apparatus and Methods for Assessing Metabolic Substrate Utilization” to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.

2 Feb 2010

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Recent data arising out of the Better Hearing Institute's "MarkeTrak" national study demonstrates that hearing loss is prevalent, serious, and often denied by the sufferer. The information revealed suggests that family members of the hearing impaired should actively encourage their loved ones to address their hearing problem, an effort which will greatly benefit both the hard of hearing and their kin.

2 Feb 2010

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Rising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.

2 Feb 2010

SDI selected for third consecutive time as key monoclonal antibody provider

SDI (Strategic Diagnostics Inc.), a leading provider of biotechnology-based products and services for a broad range of life science, food safety, and industrial applications, today announced it has been selected again by Science Applications International Corporation - Frederick (SAIC-F) to develop monoclonal antibodies for the National Cancer Institute’s “Clinical Proteomic Technologies for Cancer” initiative (CPTC: http://proteomics.cancer.gov).

2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

BioBehavioral Diagnostics completes $10M Series B financing round

BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.

1 Feb 2010

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women’s Hospital, the H. Lee Moffitt Cancer Center, Dartmouth’s Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.

1 Feb 2010

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen.

1 Feb 2010

Enzo Biochem generating more than $100M in revenues annually

Enzo Biochem, Inc. is well positioned to benefit from the results of its transformation involving acquisitions, new managements at each of its major subsidiaries and a heightened focus on new life science, diagnostic and therapeutic products, Barry Weiner, President, told the annual meeting of shareholders today.

30 Jan 2010

Humedica to participate in 7th Annual Healthcare Conference

Humedica, a next-generation clinical informatics company, today announced that it will be presenting at Harvard Business School’s 7th Annual Healthcare Conference: “Policy Reform: An Inflection Point for Healthcare Management?” on Saturday, January 30, 2010.

30 Jan 2010

Diagnostics News and Research

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Health Discovery receives final patent infringement payment from Vermillion

Researchers develop simple urine test to predict and diagnose preeclampsia

Inverness Medical Innovations to acquire Kroll's Substance Abuse Testing division

BD Diagnostics launches Be a Flu Fighter initiative to increase awareness and prevent influenza

Home Diagnostics signs definitive merger agreement with Nipro

Report: California biomedical industry faces unprecedented challenges

Micronics issued second letters patent from USPTO for integrated heat exchange system

10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

SDI selected for third consecutive time as key monoclonal antibody provider

Thermo Fisher Scientific to acquire Finnzymes

BioBehavioral Diagnostics completes $10M Series B financing round

Asuragen enters into research agreements to develop microRNA-based diagnostic test

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

Enzo Biochem generating more than $100M in revenues annually

Humedica to participate in 7th Annual Healthcare Conference

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News